Citigroup
AGN

Citigroup’s Allergan plc AGN Stock Holding History

Citigroup’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,925,753
Closed -$1.4B – 7844
2020
Q1 		$1.4B Buy
7,925,753
+2,041,670
+35% +$384M 1.27% 9
2019
Q4 		$1.12B Buy
5,884,083
+979,886
+20% +$177M 0.81% 11
2019
Q3 		$825M Buy
4,904,197
+3,698,798
+307% +$603M 0.65% 10
2019
Q2 		$202M Buy
1,205,399
+839,556
+229% +$116M 0.16% 105
2019
Q1 		$53.6M Sell
365,843
-236,671
-39% -$34.3M 0.05% 374
2018
Q4 		$80.5M Sell
602,514
-203,823
-25% -$33.4M 0.08% 238
2018
Q3 		$154M Buy
806,337
+388,824
+93% +$71.4M 0.14% 124
2018
Q2 		$69.6M Buy
417,513
+129,405
+45% +$20.8M 0.06% 257
2018
Q1 		$48.5M Sell
288,108
-488,216
-63% -$81.9M 0.04% 397
2017
Q4 		$127M Buy
776,324
+395,541
+104% +$71M 0.1% 181
2017
Q3 		$78M Buy
380,783
+41,089
+12% +$9.56M 0.06% 258
2017
Q2 		$82.6M Sell
339,694
-46,320
-12% -$10.9M 0.07% 208
2017
Q1 		$92.2M Sell
386,014
-40,198
-9% -$9.36M 0.08% 200
2016
Q4 		$89.5M Sell
426,212
-319,986
-43% -$66.3M 0.08% 233
2016
Q3 		$172M Buy
746,198
+571,933
+328% +$140M 0.16% 87
2016
Q2 		$40.3M Buy
174,265
+17,452
+11% +$4.02M 0.04% 381
2016
Q1 		$42M Buy
156,813
+33,786
+27% +$9.67M 0.05% 344
2015
Q4 		$38.4M Buy
123,027
+19,179
+18% +$5.71M 0.04% 455
2015
Q3 		$28.2M Sell
103,848
-55,675
-35% -$17.1M 0.03% 555
2015
Q2 		$48.4M Sell
159,523
-32,932
-17% -$9.82M 0.04% 404
2015
Q1 		$57.3M Buy
192,455
+20,983
+12% +$5.98M 0.06% 320
2014
Q4 		$44.1M Buy
171,472
+51,215
+43% +$12.8M 0.04% 449
2014
Q3 		$29M Sell
120,257
-8,085
-6% -$1.81M 0.03% 616
2014
Q2 		$28.4M Buy
128,342
+50,045
+64% +$10.4M 0.03% 590
2014
Q1 		$16.1M Buy
78,297
+10,814
+16% +$2.14M 0.02% 841
2013
Q4 		$11.3M Sell
67,483
-1,046
-2% -$164K 0.01% 1147
2013
Q3 		$9.87M Buy
68,529
+343
+0.5% +$45.7K 0.01% 1175
2013
Q2 		$8.61M Buy
+68,186
New +$7.72M 0.01% 1181

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citigroup's AGN Position: Q2 2020 in Review

Citigroup sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,925,753 shares — an estimated $1.4B sold.

Citigroup first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.4B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citigroup reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citigroup sold 7,925,753 Allergan plc shares in Q2 2020, an estimated $1.4B.
  • Citigroup first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Citigroup's Allergan plc position peaked at $1.4B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.